Skip to main content
. 2023 Apr 12;7:25. doi: 10.21037/med-22-50

Table 2. Comparison of spindle cell thymoma and its closest mimickers.

Tumor type Clinical Histology IHC Molecular Prognosis
Spindle cell thymoma 5th–7th decade;
M = F
Heterogeneous; classic type with storiform or diffuse growth; bland spindle/oval cells; scant lymphocytes CK+, CK5/6+, p63/p40+, Pax8 (polyclonal)+ GTF2I mutation Good
Spindle cell carcinoid tumor 5th decade; M > F Monotonous spindle cells arranged in organoid patterns CK+, synaptophysin+, chromogranin+, CD56+ Poor
Sarcomatoid thymic carcinoma 6th decade; M > F Solid or nested proliferation of malignant spindle cells; dense collagenous stroma; ± areas of spindle cell thymoma CK+, CK5/6+, CK7+, p63/p40+, Pax8 (polyclonal)+, CD5+/−, c-kit+/− Poor
SFT 6th decade; M = F Bland spindle cells in patternless pattern; keloid-like stroma; staghorn-like vasculature CD34+, STAT6+, CK NAB2::STAT6 fusion Good
Synovial sarcoma 4th decade; M > F Cellular proliferation of monotonous spindle cells; high mitotic activity; inconspicuous stroma; mast cells; staghorn-like vasculature TLE1+, SS18-SSX+/SS18_CT+, CK+/− SYT::SSX fusion Poor
Dedifferentiated liposarcoma 5th–6th decade;
M = F
Areas of well differentiated liposarcoma and non-lipogenic sarcoma (spindle cell proliferation with variable mitotic activity, nuclear pleomorphism) MDM2+ MDM2 amplification Poor
Angiosarcoma 3rd–4th decade;
M = F
Spindle cell proliferation with variable degrees of vasoformation; increased mitotic activity; necrosis CD31+, CD34+, ERG+, CK+/− Poor
Schwannoma 4th–6th decade;
M = F
Bland spindle cells with wavy appearance; Antoni A and B areas; hyalinized blood vessels; lymphoid aggregates S100+, SOX10+ Good
Inflammatory myofibroblastic tumor Children/young adults; M = F Spindle cells with indistinct cell borders; fascicular growth pattern; mixed chronic inflammatory cell infiltrate; low mitotic activity SMA+/−; ALK+/− ALK gene rearrangement Good
Sarcomatoid mesothelioma Older adults;
M > F
Spindle cells with nuclear atypia, prominent nucleoli, increased mitotic activity CK+; other mesothelioma markers variable Poor
Intimal sarcoma 5th decade;
F > M
Spindle cells with varying degrees of atypia and cellularity; subset with distinct differentiation; heterologous elements possible Variable MDM2 amplification Poor

SFT, solitary fibrous tumor; M, male; F, female; IHC, immunohistochemistry; CK, cytokeratin; ERG, erythroblast transformation specific related gene; SMA, smooth muscle actin; ALK, anaplastic lymphoma kinase.